| Thrombolytic agents in early myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 2646894 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The current revolution in the treatment of acute myocardial infarction by means of thrombolytic therapy has as its underlying strategy 3 aims: early restoration of the blood flow in order to salvage jeopardized but still viable tissues, limitation of the ultimate infarct size, and preservation, as far as possible, of ventricular function. The hope is that these 3 achievements will result in reduced short- and long-term mortality rates. The techniques used in this overall strategy are still under investigation. Three leading pharmacologic compounds vie for supremacy: streptokinase as well as its anisoylated form, recombinant technique tissue-type plasminogen activator and urokinase with or without prourokinase. In addition, the underlying anatomy may require early, or delayed, percutaneous transluminal coronary angioplasty where needed backed by coronary artery bypass grafting. Thus, the tactics of the intervention may vary from case to case and indeed from center to center depending on experience and facilities, but the conclusion is clearly the same: Early reperfusion is a must if one wishes to save ischemic but viable tissue. This report summarizes the current evidence for this new strategy. |
| | |
Authors:
|
P G Hugenholtz; H Suryapranata |
Related Documents
:
|
1557004 - Thrombolytic therapy. 17371644 - Hemorrhagic upper extremity complications from tissue plasminogen activator. 1903404 - Coronary patency, infarct size and left ventricular function after thrombolytic therapy... 8590744 - Surgical treatment of acute myocardial infarct: clinical considerations. 8000264 - Echocardiographic evaluation of anuloplasty rings. comparison of continuity equation an... 14659864 - Acute pulmonary edema after cardioversion of cardiac arrhythmias. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The American journal of cardiology Volume: 63 ISSN: 0002-9149 ISO Abbreviation: Am. J. Cardiol. Publication Date: 1989 Mar |
Date Detail:
|
Created Date: 1989-04-13 Completed Date: 1989-04-13 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 94E-101E Citation Subset: AIM; IM |
Affiliation:
|
Department of Cardiology, University Hospital, Erasmus University, Rotterdam, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Fibrinolytic Agents
/
therapeutic use* Humans Myocardial Infarction / drug therapy* Streptokinase / administration & dosage Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents; EC 3.4.-/Streptokinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Is there a true increase in myocardial stiffness with acute ischemia?
Next Document: Effects of simvastatin and probucol in hypercholesterolemia (Simvastatin Multicenter Study Group II)...